Nanobody CAR-T cells in cancer: From molecular design to clinical translation
{{output}}
Chimeric antigen receptor (CAR)-T cell therapy has revolutionized the management of hematologic malignancies. This review provides an overview of nanobody-based CAR-T therapy, highlighting how structural advancements in single-domain antibody (VHH) design enha... ...
